Biobased and Renewable Products News: Capitol Hill

November 9, 2018
Call For Candidate Chemicals For Equivalency Determinations
Is your company engaged in Class 2 chemistries that are similar to existing Class 2 chemicals but are derived from an innovative bio-source? We are looking for pioneering companies working on new biobased Class 2 chemicals to assist in advancing an important project with the U.S. Environmental Protection Agency (EPA).   ISSUE:  While EPA sustainability goals would seemingly include adoption of improved biobased technologies, EPA’s policies under the Toxic Substances Control Act (TSCA) mean that many novel, sustainable technologies are considered “new chemicals” ... read more >
April 19, 2019
Warren Writes Article Declaring Her Plan For Public Lands
On April 15, 2019, U.S. Senator Elizabeth Warren (D-MA) wrote an article for Medium Politics, titled “My plan for public lands.” In the article, Warren highlights the importance and value of U.S. public lands and the need to make them part of the climate solution rather than the issue. Emphasizing her position on corporate profits and how they should not be prioritized over local communities’ health and safety, Warren states that on her first day in office as President, she will “sign an executive order that says no more drilling—a total moratorium on all new ... read more >
March 22, 2019
Fuel Choice And Deregulation Act Introduced In Senate
On February 27, 2019, Senators Rand Paul (R-KY) and Chuck Grassley (R-IA) introduced the Fuel Choice and Deregulation Act of 2019 (S. 581).  The legislation would remove “burdensome” regulations on domestic energy production.  The bill “provides new economic opportunity for Kentucky farmers by allowing fuel producers and automobile manufacturers to innovate and bring new products to market that will lower costs for consumers, increase domestic energy production, and protect the environment,” said Senator Paul.  The Fuel Choice and Deregulation Act would ... read more >
March 1, 2019
Consolidated Appropriations Act, 2019, Signed Into Law
On February 15, 2019, U.S. President Donald Trump signed into law a bill originally introduced in early 2017 by Representative Nita Lowey (D-NY) titled the Consolidated Appropriations Act, 2019 (2019 Appropriations Act). Of interest to stakeholders in the biobased sector is Section 428, which covers policies relating to biomass energy.  In this section, responsibilities assigned to the U.S. Secretary of Energy, Secretary of Agriculture, and EPA Administrator are outlined in support of the key role forests play in addressing U.S. energy needs.  Among these responsibilities are ... read more >
February 15, 2019
U.S. Representative Ocasio-Cortez Releases Green New Deal
On February 7, 2019, Representative Ocasio-Cortez (D-NY), in partnership with Senator Ed Markey (D- MA), released the outline for the Green New Deal, a policy package designed to reduce greenhouse gas (GHG) emissions through the transformation of the U.S. economy. The outline includes highlights on the systemic impact from climate change, particularly on women, indigenous populations, deindustrialized and migrant communities, the poor, communities of color, depopulated rural communities, low-income workers, the elderly, the unhoused, people with disabilities, and youth. Stating that climate ... read more >
January 18, 2019
Environmental Groups Urge U.S. Representatives To Continue Push For A Green New Deal
On January 10, 2019, more than 600 environmental groups signed a letter submitted to U.S. Representatives urging them to consider certain principles on climate change as a Green New Deal is developed.  As the 116th Congress begins to take into account climate change legislation, environmental groups would like to see affirmative actions focused on six key areas: Fossil fuel phase-out; Transition into renewable energy; The role of public transportation; The power of the Clean Air Act (CAA); Community-led transitions; and, The importance of indigenous rights. Tying together these ... read more >
January 11, 2019
B&C Releases 2019 Forecast On U.S. Federal And International Chemical Regulatory Policy
On January 8, 2019, B&C and its consulting affiliate The Acta Group (Acta®) published the 2019 Forecast.  The document details the legal, scientific, and regulatory trends in U.S. and global chemical law, providing informed judgment as to the shape of key developments we are likely to see in 2019.  Sections on biobased products and biotechnology are included in the document.  The full document can be accessed ... read more >
December 21, 2018
Democratic Leader Requests Clean Energy Infrastructure Package In 2019
On December 6, 2018, U.S. Senator Charles E. Schumer (D-NY) wrote a letter to President Donald Trump requesting that, in 2019, any infrastructure package to be considered include a focus on the clean energy economy to address climate change. Emphasizing that climate change is, in fact, real and caused by humans, Senator Schumer refers to the Administration’s recent National Climate Assessment report and the drastic need to reduce emissions. In the letter, Senator Schumer outlines a number of policies that must be included in an infrastructure package in the next Congress. Among these ... read more >
November 9, 2018
FDA Submits A Collection Of Information Proposal To OMB
On November 5, 2018, the U.S. Food and Drug Administration (FDA) announced that a proposed collection of information on the Biosimilars User Fee Program was submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. FDA’s Biosimilars User Fee Program was established under the Biologics Price Competition and Innovation Act of 2009 (BPCI Act), which amended the Public Health Service Act through the addition of Section 351(k). The BPCI Act also amended the Federal Food, Drug, and Cosmetic Act to include Section 351(k) under ... read more >
November 2, 2018
FDA Releases Statement On A New Plant And Animal Biotechnology Innovation Action Plan
On October 30, 2018, the U.S. Food and Drug Administration (FDA) published a statement by FDA Commissioner Scott Gottlieb, M.D., and FDA Deputy Commissioner Anna Abram regarding FDA’s new action plan to advance plant and animal biotechnology innovation.  Aimed at ensuring the safety of plant and animal biotechnology products and avoiding unnecessary barriers to future innovation, the Action Plan focuses on three key priorities: Advancing public health by promoting innovation; Strengthening public outreach and communication; and Increasing engagement with domestic and ... read more >
 1 2 3 >  Last › View 10 | 25 | 50 | 100 per page
 
BIOBASED AND RENEWABLE PRODUCTS ADVOCACY GROUP
2200 Pennsylvania Avenue, NW, Suite 100W
Washington, D.C. 20037
(202) 833-6580 | www.braginfo.org
Contact
 
Privacy Policy | Acceptable Use Policy 
©2019 Biobased And Renewable Products Advocacy Group
All Rights Reserved.